Chercheur

    Michèle David , M.D.

    michele.david@umontreal.ca
    Axe de recherche
    Santé métabolique et maladies complexes
    Thème de recherche
    Soins aigus et médecine transfusionnelle
    Adresse
    CHUSJ

    Téléphone
    514 345-4931 #4639

Publications

Bleeding in congenital hemangiomas: crusting as a clinical predictive sign and usefulness of Tranexamic acid - Powell J, Blouin MM, David M, Dubois J. Bleeding in congenital hemangiomas: crusting as a clinical predictive sign and usefulness of Tranexamic acid. Pediatr Dermatol 2012; 29(2): 182-185.

A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma - McCuaig C, Dubois J, Powell J, Belleville C, David M, Rousseau E, Gendron R, Jafarian F, Auger I. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma. Pediatr Dermatol 2009; 26(2): 203-212.

Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial - Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N, Morin F, Demers C, Kahn SR, Magee LA, Rodger M. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. Eur Respir J 2009; 7(1): 58-64.

Lemierre syndrome: two preschool children with cerebral infarcts - case reports - Santschi M, Garel L, David M, Vanasse M, Gauvin F. Lemierre syndrome: two preschool children with cerebral infarcts - case reports. Clin Med Pediatrics 2008; 1: 13-18.

Thrombocytose - David M, Weber M. Thrombocytose. Dans: Turgeon J, Bernard-Bonnin AC, Gervais P, Ovetchkine P, Gauthier M (eds). Dictionnaire de thérapeutique pédiatrique Weber, 2e édition. Boucherville. Gaëtan Morin, 2007; 1210-1211.

Coagulation intravasculaire disséminée - David M, Desmet L, Hazelzet J, Leclerc F. Coagulation intravasculaire disséminée. Dans: Lacroix J, Gauthier M, Hubert P, Leclerc F, Gaudreault P (eds). Urgences et soins intensifs pédiatriques. Montréal et Paris. Éditions du CHU Sainte-Justine et Elsevier Masson, 2007; 515-525.

Thomboses - David M, Noizet-Yverneau O, Desmet L, Beaufils F, Dubois J. Thomboses. Dans: Lacroix J, Gauthier M, Hubert P, Leclerc F, Gaudreault P (eds). Urgences et soins intensifs pédiatriques. Montréal et Paris. Éditions du CHU Sainte-Justine et Elsevier Masson, 2007; 527-546.

Purpura thombopénique idiopathique - Gravel J, David M. Purpura thombopénique idiopathique. Dans: Turgeon J, Bernard-Bonnin AC, Gervais P, Ovetchkine P, Gauthier M (eds). Dictionnaire de thérapeutique pédiatrique Weber, 2e édition. Boucherville. Gaëtan Morin, 2007; 1065-1068.

Thromboses veineuses et artérielles - Robitaille N, David M. Thromboses veineuses et artérielles. Dans: Turgeon J, Bernard-Bonnin AC, Gervais P, Ovetchkine P, Gauthier M (eds). Dictionnaire de thérapeutique pédiatrique Weber, 2e édition. Boucherville. Gaëtan Morin, 2007; 1211-1217.

Management of alloimmune thrombocytopenia - Kanhai H, Porcelijn L, Engelfriet CP, Reesink HW, Panzer S, Ulm B, Goldman M, Bonacossa I, Richard L, David M, Taaning E, Hedegaard M, Kaplan C, Kiefel V, Meyer O, Salama A, Morelati F, Greppi N, Marconi M, Tassis B, Tsuno NH, Takahashi K, Oepkes D, Porcelijn L, Kanhai H, Cameron A, Osnes LT, Husebekk A, Killie MK, Kjeldsen-Kragh J, Zupanska B, Muñiz-Diaz E, Nogués N, Parra J, Urbaniak SJ. Management of alloimmune thrombocytopenia. Vox Sang 2007; 93(4): 370-385.

Maladie de Kawasaki - Decaluwé H, Dahdah NS, David M, Fournier A. Maladie de Kawasaki. Dans: Turgeon J, Bernard-Bonnin AC, Gervais P, Ovetchkine P, Gauthier M (eds). Dictionnaire de thérapeutique pédiatrique Weber, 2e édition. Boucherville. Gaëtan Morin, 2007; 817-820.

Complications of apheresis in children - Michon B, Moghrabi A, Winikoff R, Barrette S, Bernstein M, Champagne J, David M, Duval M, Hume HA, Robitaille N, Belisle A, Champagne M. Complications of apheresis in children. Transfusion 2007; 47: 1837-1842.

Chronic immune thrombocytopenic purpura in children: a survey of the Canadian experience - Belletrutti M, Ali K, Barnard D, Blanchette V, Chan A, David M, Luke B, Price V, Ritchie B, Wu J, Canadian Pediatric Chronic ITP Working Group, Canadian Pediatric Thrombosis and Hemostasis Network. Chronic immune thrombocytopenic purpura in children: a survey of the Canadian experience. J Pediatr Hematol Oncol 2007; 29(2): 95-100.

Incidence of deep vein thrombosis related to peripherally inserted central catheters (PICC) in children - Dubois J, Rypens FF, Garel L, David M, Lacroix J, Gauvin F. Incidence of deep vein thrombosis related to peripherally inserted central catheters (PICC) in children. CMAJ 2007; 177(10): 1185-1190.

Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia - Leduc L, Dubois E, Takser L, Rey E, David M. Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia. J Obstet Gynaecol Can 2007; 29(10): 787-793.

Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis - Optarny L, David M, Kahn SR, Shrier I, Rey E. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol 2006; 33(11): 2214-2221.

Gynaecological and obstetric management of women with inherited bleeding disorders - Demers C, Derzko C, David M, Douglas J. Gynaecological and obstetric management of women with inherited bleeding disorders. Int J Gynecol Obstet 2006; 95(1): 75-87.

The potential efficacy of omega-3 fatty acids as anti-angiogenic agents in benign vascular tumors of infancy - Sterescu A, Rousseau-Harsany E, Farrell CA, Powell J, David M, Dubois J. The potential efficacy of omega-3 fatty acids as anti-angiogenic agents in benign vascular tumors of infancy. Med Hypotheses 2006; 66(6): 1121-1124.

Venous thromboembolism after severe injury in children - Cyr C, Michon B, Pettersen G, David M, Brossard J. Venous thromboembolism after severe injury in children. Acta Haematol 2006; 115(3-4): 198-200.

The use of LMWH in pregnancies at risk: new evidence or perception? - Rey E, David M. The use of LMWH in pregnancies at risk: new evidence or perception?. J Thromb Haemost 2005; 3(4): 782-783.

Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations - Vallette-Kasic S, Brue T, Pulichino A-M, Gueydan M, Barlier A, David M, Nicolino M, Malpuech G, Déchelotte P, Deal C, Van Vliet G, De Vroede M, Riepe FG, Partsch CJ, Sippell WG, Berberoglu M, Atasay B, de Zegher F, Beckers D, Kyllo J, Donohoue P, Fassnacht M, Hahner S, Allolio B, Noordam K, Dunkel L, Hero M, Pigeon B, Weill J, Yigit S, Brauner R, Heinrich JJ, Cummings E, Riddell C, Enjalbert A, Drouin J. Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations. J Clin Endocrinol Metab 2005; 90(3): 1323-1331.

Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols - Dalle JH, Moghrabi A, Rousseau P, Leclerc JM, Barrette S, Bernstein M, Champagne J, David M, Demers J, Duval M, Hume HA, Meyer P, Champagne M. Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols. J Pediatr Hematol Oncol 2005; 27(2): 73-79.

Gynaecological and obstetric management of women with inherited bleeding disorders - Demers C, Derzko C, David M, Douglas J. Gynaecological and obstetric management of women with inherited bleeding disorders. J Obstet Gynaecol Can 2005; 27(7): 707-732.

Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus - Male C, Foulon D, Hoogendoorn H, Vegh P, Silverman E, David M, Mitchell L. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 2005; 106(13): 4152-4158.

Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow - Dalle JH, Duval M, Moghrabi A, Wagner É, Vachon MF, Barrette S, Bernstein M, Champagne J, David M, Demers J, Rousseau P, Winikoff R, Champagne M. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant 2004; 33(6): 605-611.

A neonatal form of isolated ACTH deficiency frequently associated with Tpit gene mutations - Vallette-Kasic S, Pulichino A-M, Gueydan M, Barlier A, David M, Malpuech G, Deal C, Van Vliet G, De Vroede M, Riepe FG, Partsch CJ, Sippell WG, Berberoglu M, Atasay B, de Zegher F, Kyllo J, Donohoue P, Déchelotte P, Fassnacht M, Noordam K, Dunkel L, Pigeon B, Weill J, Yigit S, Brauner R, Léger J, Heinrich JJ, Enjalbert A, Brue T, Drouin J. A neonatal form of isolated ACTH deficiency frequently associated with Tpit gene mutations. Endocr Res 2004; 30(4): 943-944.

Canadian contraception consensus - Black A, Francoeur D, Rowe T, Collins J, Miller D, Brown T, David M, Dunn S, Fisher W, Fleming N, Fortin C, Guilbert E, Hanvey L, Lalonde A, Miller R, Morris M, O'Grady T, Pymar H, Smith T, Henneberg E. Canadian contraception consensus. J Obstet Gynaecol Can 2004; 26(2): 143-156; 158-174.

SOGC clinical practice guidelines: Canadian contraception consensus - Black A, Francoeur D, Rowe T, Collins J, Miller D, Brown T, David M, Dunn S, Fisher W, Fleming N, Fortin C, Guilbert E, Hanvey L, Lalonde A, Miller R, Morris M, O'Grady T, Pymar H, Smith T, Henneberg E. SOGC clinical practice guidelines: Canadian contraception consensus. J Obstet Gynaecol Can 2004; 26(3): 219-296.

Canadian contraception consensus - Black A, Francoeur D, Rowe T, Collins J, Miller D, Brown T, David M, Dunn S, Fisher W, Fleming N, Fortin C, Guilbert E, Hanvey L, Lalonde A, Miller R, Morris M, O'Grady T, Pymar H, Smith T, Henneberg E. Canadian contraception consensus. J Obstet Gynaecol Can 2004; 26(4): 347-87, 389-436.

HPA-5b (Bra) neonatal alloimmune thrombocytopenia in Quebec: incidence and clinical outcome in 31 cases - Rousseau J, Goldman M, David M. HPA-5b (Bra) neonatal alloimmune thrombocytopenia in Quebec: incidence and clinical outcome in 31 cases. Transfusion 2004; 44(6): 844-888.

Development of a disease-specific health-related quality-of-life instrument for children and parents of children with immune thrombocytopenic purpura - Barnard D, Woloski M, Feeney D, McCusker J, Wu J, David M, Bussel J, Lusher J, Wakefield C, Henriques S, Blanchette V, for the Canadian Children's Platelet Study Group. Development of a disease-specific health-related quality-of-life instrument for children and parents of children with immune thrombocytopenic purpura. J Pediatr Hematol Oncol 2003; 25(1): 56-62.

Prenatal management of alloimmune thrombocytopenia of the fetus - Engelfriet CP, Reesink HW, Kroll H, Giers G, Bald R, Kanhai H, Kekomaki R, Teramo K, Panzer S, Jilma R, Ulm B, Bock J, Taaning E, Rodeck B, Goldman M, David M, Kaplan C. Prenatal management of alloimmune thrombocytopenia of the fetus. Vox Sang 2003; 84: 142-149.

An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial - Massicotte P, Julian J, Gent M, Shields K, Marzinotto V, Szechtman B, Chan AKC, Andrew M, David M, the PROTEKT Study Group. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thromb Res 2003; 109: 101-108.

An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial - Massicotte P, Julian J, Gent M, Shields K, Marzinotto V, Szechtman B, Andrew M, David M, the REVIVE Study Group. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb Res 2003; 109: 85-92.

Thrombophilic disorders and fetal loss: a meta-analysis - Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003; 361(9361): 901-908.

Alternatives to intravenous immunoglobulins in the treatment of immune thrombocytopenic purpura - David M, Chevalier I. Alternatives to intravenous immunoglobulins in the treatment of immune thrombocytopenic purpura. Vox Sang 2002; 83 (suppl. 1): 443-445.

Association between factor V Leiden mutation and the hemiconvulsion, hemiplegia, and epilepsy syndrome: report of two cases - Scantlebury M, David M, Carmant L. Association between factor V Leiden mutation and the hemiconvulsion, hemiplegia, and epilepsy syndrome: report of two cases. J Child Neurol 2002; 17(9): 713-717.

Vascular soft-tissue tumors in infancy: distinguishing features on Doppler sonography - Dubois J, Garel L, David M, Powell J. Vascular soft-tissue tumors in infancy: distinguishing features on Doppler sonography. Am J Roentgenol 2002; 178(6): 1541-1545.

Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production - Semple JW, Allen D, Rutherford M, Woloski M, David M, Wakefield C, Butchard S, Freedman J, Blanchette V, for the Canadian Children's Platelet Study Group. Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production. Am J Hematol 2002; 69(3): 225-227.

Cerebral sinovenous thrombosis in children - de Veber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, Camfield CS, David M, Humphreys P, Langevin P, Macdonald A, Gillett J. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345: 417-423.

Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus - Male C, Mitchell L, Julian J, Vegh P, Joshua P, Adams M, David M, Andrew M. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 2001; 97: 844-849.

A comparative study of the efficacy of urokinase and recombinant tissue plasminogen activator to restore the patency of occluded central venous catheters in children - Bussières J-F, Therrien R, David M, Leclair JP, Harel F. A comparative study of the efficacy of urokinase and recombinant tissue plasminogen activator to restore the patency of occluded central venous catheters in children. J Pharm Technol 2001; 17: 95-98.

Selected abstracts - Laverdière C, David M, Dubois J, Russo P, Hershon L, Lapierre J-G. Selected abstracts. Pediatr Pulmonol 2000; 29(4): 325-328.

Improvement of disseminated lymphangiomatosis with recombinant interferon therapy - Laverdière C, David M, Dubois J, Russo P, Hershon L, Lapierre J-G. Improvement of disseminated lymphangiomatosis with recombinant interferon therapy. Pediatr Pulmonol 2000; 29: 321-324.

Outcome of pediatric thromboembolic disease: A report from the Canadian Childhood Thrombophilia Registry - Monagle P, Adams M, Mahoney M, Ali K, Bernard D, Bernstein M, Brisson L, David M, Desai S, Scully MF, Halton J, Israel S, Jardine L, Leaker M, McCusker P, Silva M, Wu J, Anderson R, Andrew M, Massicotte P. Outcome of pediatric thromboembolic disease: A report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47: 763-766.

Stroke in children: the coexistence of multiple risk factor predicts poor outcome - Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G. Stroke in children: the coexistence of multiple risk factor predicts poor outcome. Neurology 2000; 54(2): 371-378.

The burden of childhood ITP - Barnard D, Blanchette V, David M. The burden of childhood ITP. Intern J Pediatr Hematol Oncol 2000; 7(1): 13-15.

Hemolytic uremic syndrome associated with invasive streptococcus pneumoniae infection - Proulx F, Liet JM, David M, Seidman EG, Tapiero B, Robitaille P, Lacroix J. Hemolytic uremic syndrome associated with invasive streptococcus pneumoniae infection. Pediatr Res 2000; 105: 462-463.

Toxicity profile of interferon alfa-2b in children: A prospective evaluation - Dubois J, Hershon L, Carmant L, Bélanger S, Leclerc JM, David M. Toxicity profile of interferon alfa-2b in children: A prospective evaluation. J Pediatr 1999; 135: 782-785.

Soft tissue hemangiomas in infants and children: Diagnosis with Doppler sonography - Dubois J, Patriquin HB, Garel L, Powell J, Filiatrault D, David M, Grignon A. Soft tissue hemangiomas in infants and children: Diagnosis with Doppler sonography. Am J Roentgenol 1998; 171: 247-252.

Incidence and risk factors of catherter-related deep vein thrombosis in a Pediatric Intensive Care Unit. A Prospective Study - Beck C, Dubois J, Grignon A, Lacroix J, David M. Incidence and risk factors of catherter-related deep vein thrombosis in a Pediatric Intensive Care Unit. A Prospective Study. J Pediatr 1998; 133: 237-241.

The relationship of antiphospholipid antibodies to thromboembolic events in children with systemic lupus erythematosus: A cross-sectional study - Bérubé C, Mitchell L, Silverman E, David M, St-Cyr C, Laxer R, Adams M, Vegh P, Andrew M. The relationship of antiphospholipid antibodies to thromboembolic events in children with systemic lupus erythematosus: A cross-sectional study. Pediatr Res 1998; 444(3): 351-356.

A cross-Canada survey of prothrombin time testing. Does the establishment of local ISI values improve the accuracy of international normalized ratio reporting - Johnston M, Brigden L, for the Thrombosis Interest Group of Canada, David M. A cross-Canada survey of prothrombin time testing. Does the establishment of local ISI values improve the accuracy of international normalized ratio reporting. Am J Clin Pathol 1998; 110: 683-690.

Causes of death in Canadians with Hemophilia 1980-1995 - Walker IR, and the Association of Hemophilia Clinic Director of Canada, David M, Rivard G-É. Causes of death in Canadians with Hemophilia 1980-1995. Haemophilia 1998; 4: 714-720.

Imaging of hemangiomas and vascular malformations in children - Dubois J, Garel L, Grignon A, David M, Caouette-Laberge L, Filiatrault D, Powell J. Imaging of hemangiomas and vascular malformations in children. Acad Radiol 1998; 5(5): 390-400.

Arterial thromboembolic complications in paediatric patients - Andrew M, David M, de Veber G, Brooker LA. Arterial thromboembolic complications in paediatric patients. Thromb Haemost 1997; 78: 715-725.

Peripherally inserted central catherers in infants and children - Dubois J, Garel L, Tapiero B, Dubé J, Laframboise S, David M. Peripherally inserted central catherers in infants and children. Radiology 1997; 204: 622-626.

Anticoagulation without catheter removal in children with catheter-related central vein thrombosis - Kenney BD, David M, Bensoussan A. Anticoagulation without catheter removal in children with catheter-related central vein thrombosis. J Pediatr Surg 1996; 31: 816-818.

À propos de cette page

Créée le 22 juillet 2014
Signaler ou faire une remarque

Chaque dollar compte !

Merci de votre générosité.

Ce sont les donateurs comme vous qui nous permettent d’accélérer la recherche, de guérir, à chaque année, plus d’enfants et continuer d’offrir un des meilleurs niveaux de santé au monde.

Il est également possible de donner par la poste ou de donner par téléphone au numéro sans frais

1-888-235-DONS (3667)

Nous contacter

514 345-4931

Légal

© 2006-2014 Centre de recherche du CHU Sainte-Justine.
Tous droits réservés.
Avis légaux  Confidentialité  Sécurité

Avertissement

Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine